Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  A M A Archives of Ophthalmology

• Publication date

  1989-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHOPHT.1989.01070020668025PMID 2818278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of topical timolol maleate on the ophthalmic artery blood pressure.

  1989cited by this paper
• The effect of long-term intraocular pressure reduction on the differential light sensitivity in glaucoma suspects.

  1988cited by this paper
• Early diagnosis of glaucoma

  1987cited by this paper
• Bilateral effects of long-term monocular timolol therapy.

  1987cited by this paper
• A case-control study of risk factors in open angle glaucoma.

  1987cited by this paper
• Ocular hypertension

  1987cited by this paper
• Prognostic factors in the development of manifest open angle glaucoma. A long-term follow-up study of hypertensive and normotensive eyes.

  1986cited by this paper
• Effect of topical timolol on the human retinal circulation.

  1986cited by this paper
• Effects of antiglaucoma drugs on the blood flow in rabbit eyes.

  1986cited by this paper
• Prognostic factors in the development of manifest open angle glaucoma

  1986cited by this paper
• Effect of timolol on optic nerve head autoregulation.

  1986cited by this paper
• Race as a risk factor for progressive glaucomatous damage.

  1985cited by this paper
• Race and primary open-angle glaucoma.

  1985cited by this paper
• Detection of increased pallor over time. Computerized image analysis in untreated ocular hypertension.

  1985cited by this paper
• The reproducibility of computerized boundary analysis for measuring optic disc pallor in the normal optic disc.

  1985cited by this paper
• Race, iris pigmentation, and intraocular pressure.

  1982cited by this paper
• Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction.

  1982cited by this paper
• MANIFEST GLAUCOMA IN THE AGED I: OCCURRENCE NINE YEARS AFTER A POPULATION SURVEY

  1981cited by this paper
• Prophylactic therapy of ocular hypertension. A prospective study.

  1981cited by this paper
• Multivariate analysis in glaucoma. Use of discriminant analysis in predicting glaucomatous visual field damage.

  1981cited by this paper
• Prognostic indicators in ocular hypertension.

  1980cited by this paper
• Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

  1980cited by this paper
• Timolol: its effectiveness in different types of glaucoma.

  1979cited by this paper
• Multivariate analysis of the risk of glaucomatous visual field loss.

  1979cited by this paper
• Timolol. A new drug for management of chronic simple glaucoma.

  1978cited by this paper
• OCULAR HYPERTENSION. A 15‐YEAR FOLLOW‐UP

  1978cited by this paper
• Use of Discriminant Analysis: II. Identification of Persons With Glaucomatous Visual Field Defects

  1978cited by this paper
• Ocular hypertension--a long-term follow-up of treated and untreated patients.

  1977cited by this paper
• Untreated ocular hypertension. A long-term prospective study.

  1977cited by this paper
• 'Ocular hypertension' vs open-angle glaucoma.

  1977cited by this paper
• 'Ocular hypertension' vs open-angle glaucoma: a different view.

  1977cited by this paper
• Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

  1977cited by this paper
• Timolol: A β-Adrenergic Blocking Agent for the Treatment of Glaucoma

  1977cited by this paper
• 'Ocular Hypertension' or 'Early Glaucoma'? 'Ocular Hypertension' vs Open-Angle Glaucoma

  1977cited by this paper
• Ocular hypertension: to treat or not to treat.

  1977cited by this paper
• Long-term epinephrine therapy of ocular hypertension.

  1976cited by this paper
• OCULAR HYPERTENSION

  1976cited by this paper
• Uniocular miotic therapy.

  1975cited by this paper
• Ocular hypertension. Follow-up of 109 cases from 1963 to 1974.

  1974cited by this paper
• The Bedford glaucoma survey. I. Long-term follow-up of borderline cases.

  1973cited by this paper
• ROUTINE TONOMETRY IN OPHTHALMIC PRACTICE

  1970cited by this paper
• Routine tonometry in ophthalmic practice. II. Five-year follow-up.

  1970cited by this paper
• The definition of pre-glaucoma. A prospective study.

  1969cited by this paper
• Ocular pressure and visual fields. A ten-year follow-up study.

  1969cited by this paper
• Topical epinephrine in glaucoma suspects.

  1966cited by this paper

• Basis of Approval for Glaucoma Drugs and Devices: 2003-2025.

  2026cites this paper
• Primary Practice Patterns for the Initial Management of Open Angle Glaucoma

  2024cites this paper
• Efficacy and Safety of Netarsudil versus Timolol in Glaucoma Patients: A Systematic Review and Meta-analysis

  2024cites this paper
• Early postoperative visual acuity changes after trabeculectomy and factors affecting visual acuity

  2023cites this paper
• Risk Calculation in the Medication Arm of the Ocular Hypertension Treatment Study.

  2023cites this paper
• THE NATURAL HISTORY OF UNTREATED OCULAR HYPERTENSION AND GLAUCOMA PATIENTS.

  2022cites this paper
• Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2022cites this paper
• A comparative study of timolol plus either brimonidine (0.2%) or dorzolamide (2%) or latanoprost (0.005%) dual therapy in suboptimal responders to timolol (0.5%) monotherapy among patients of open-angle glaucoma, ocular hypertension, and normal-tension glaucoma

  2021cites this paper
• Lifetime Risk of Visual Impairment Resulting from Glaucoma in Patients Initially Followed up for Elevated Intraocular Pressure.

  2020cites this paper
• Medical Management of Glaucoma

  2020cites this paper
• [Cyclodestructive Procedures to Lower Intraocular Pressure - A Review].

  2019cites this paper
• [Modern view on ocular hypertension].

  2019cites this paper
• Variable expression of alpha-2-macroglobulin and tumor necrosis factor-α in the aqueous humor of patients with pseudoexfoliative syndrome with and without glaucoma

  2018cites this paper
• Zyklodestruktive Verfahren zur Senkung des Augeninnendrucks – eine Übersicht

  2017cites this paper
• Change in Visual Field Progression Following Treatment Escalation in Primary Open-angle Glaucoma

  2017cites this paper
• Ocular Hypertension: A Review And Evidence-Based Roadmap

  2017cites this paper
• Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus

  2017cites this paper
• Evaluating and optimising glaucoma referral refinement pathways with specific reference to the changes scheme

  2016cites this paper
• Incidence of and risk factors for glaucoma in lost-to-follow-up normal-tension glaucoma suspect patients

  2016cites this paper
• Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma

  2016cites this paper
• Developmental disorders: deciphering exomes on a grand scale.

  2015cites this paper
• Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study

  2015cites this paper
• 52 – Prostaglandin Analogues

  2015cites this paper
• A Quarter Century's Progress in the Treatment of Open-Angle Glaucoma.

  2015cites this paper
• 29 – Primary Open-Angle Glaucoma

  2015cites this paper
• Glaucoma treatment: by the highest level of evidence.

  2015cites this paper
• Ocular Hypertension and the Risk of Blindness

  2015cites this paper
• Comparison of Dynamic Contour Tonometry and Goldmann Applanation Tonometry in Relation to Central Corneal Thickness

  2015cites this paper
• Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus

  2014cites this paper
• Assessment of Kenyan ophthalmic clinical officer’s knowledge, skills and practice on glaucoma

  2014cites this paper
• Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus

  2014cites this paper
• Morphological and Hydrodynamic Correlations with Increasing Outflow Facility by Rho-Kinase Inhibitor Y-27632

  2014cites this paper
• Patient-related and system-related barriers to glaucoma follow-up in a county hospital population.

  2013cites this paper
• Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost‐effectiveness analysis

  2012influential citation
• Avaliação da eficácia do bimatoprosta 0,03% (Glamigan, Germed, Brasil) na redução da pressão intraocular em pacientes com glaucoma primário de ângulo aberto e hipertensão ocular

  2012cites this paper
• Glaucoma severity and medication adherence in a county hospital population.

  2012cites this paper
• Surveillance for ocular hypertension: an evidence synthesis and economic evaluation.

  2012cites this paper
• The association between compliance with recommended follow-up and glaucomatous disease severity in a county hospital population.

  2012cites this paper
• Treating Ocular Hypertension to Reduce Glaucoma Risk

  2012cites this paper
• During glaucoma, alpha2-macroglobulin accumulates in aqueous humor and binds to nerve growth factor, neutralizing neuroprotection.

  2011cites this paper
• The Clinical Impact of 2 Different Strategies for Initiating Therapy in Patients With Ocular Hypertension

  2011cites this paper
• Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial.

  2011cites this paper
• Perimetry, tonometry and epidemiology: the fate of glaucoma management

  2011cites this paper
• Continuous Monitoring of Intraocular Pressure

  2010cites this paper
• Quantifying the effect of intraocular pressure reduction on the occurrence of glaucoma

  2010cites this paper
• Ocular Hypertension Treatment Study.

  2009cites this paper
• Peripheral colour contrast thresholds in ocular hypertension and glaucoma.

  2009cites this paper
• Decrease of optic disc cupping and pallor of ocular hypertensives with timolol therapy.

  2009cites this paper
• Increase of retinal vessel width in ocular hypertensives with timolol therapy.

  2009cites this paper
• Increase of retinal nerve fiber layer thickness in ocular hypertensives with timolol therapy.

  2009cites this paper
• Evidence-Based Medicine in Glaucoma

  2009cites this paper
• CHAPTER 22 – Medical treatment of glaucoma: general principles

  2009cites this paper
• MEDICAL MANAGEMENT OF GLAUCOMA: AN OVERVIEW

  2009cites this paper
• α2-Macroglobulin Is a Mediator of Retinal Ganglion Cell Death in Glaucoma*

  2008cites this paper
• A Validated Prediction Model for the Development of Primary Open Angle Glaucoma in Individuals with Ocular Hypertension The Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study Group

  2008cites this paper
• Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.

  2007cites this paper
• Evolving global risk assessment of ocular hypertension to glaucoma

  2007cites this paper
• Primary open-angle glaucoma and ocular hypertension : cost-effectiveness of early detection and treatment

  2007cites this paper
• Chapter 14 – Drugs for the treatment of glaucoma

  2007cites this paper
• Medical interventions for primary open angle glaucoma and ocular hypertension.

  2007cites this paper
• Biological Considerations for an Intraocular Retinal Prosthesis

  2007cites this paper
• Potentially unintended discontinuation of long-term medication use after elective surgical procedures.

  2006cites this paper
• Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.

  2006cites this paper
• Factors associated with failure to follow up after glaucoma screening: a study in an African American population.

  2006cites this paper
• Treating ocular hypertension to reduce glaucoma risk: when to treat?

  2006cites this paper
• Aspects of FDP in the Detection of Early Glaucoma

  2006cites this paper
• Care of the Patient with Open Angle Glaucoma

  2006influential citation
• Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials

  2005cites this paper
• Risk of glaucoma in ocular hypertension with and without pseudoexfoliation.

  2005cites this paper
• Continuous Monitoring of Circadian Variations in Intraocular Pressure by Telemetry System Throughout a 12-Week Treatment with Timolol Maleate in Rabbits

  2005influential citation
• Results of the European Glaucoma Prevention Study The European Glaucoma Prevention Study ( EGPS ) Group *

  2005cites this paper
• Pneumatic trabeculoplasty a new method to treat primary open-angle glaucoma and reduce the number of concomitant medications

  2005cites this paper
• European Glaucoma Prevention Study: Author reply

  2005cites this paper
• [Results of the "Ocular hypertension treatment study"].

  2005cites this paper
• SCREENING FOR VISUAL PROBLEMS AMONG ELDERLY PATIENTS Canadian Task Force on the Periodic Health Examination

  2005cites this paper
• Results of the European Glaucoma Prevention Study.

  2005cites this paper
• Ergebnisse der „Ocular hypertension treatment study“ (OHTS)

  2005cites this paper
• Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.

  2005cites this paper
• Changes of color vision in ocular hypertension

  2004cites this paper
• The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals.

  2004cites this paper
• What is the gold standard in glaucoma diagnosis

  2004cites this paper
• An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma.

  2004cites this paper
• Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma.

  2004cites this paper
• The Ocular Hypertension Treatment Study Topical Medication Delays or Prevents Primary Open-angle Glaucoma in African American Individuals

  2004cites this paper
• Medical Outcomes of Glaucoma Therapy from a Nationwide Representative Survey

  2004cites this paper
• Glaucoma therapy : current issues and controversies

  2003cites this paper
• Latanoprost

  2003cites this paper
• A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension

  2003cites this paper
• The Finnish evidence-based guideline for open-angle glaucoma.

  2003cites this paper
• Pros and Cons of Ocular Hypotensive Lipids

  2003cites this paper
• Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects.

  2003cites this paper
• Evidence-based medicine The Finnish evidence-based guideline for open-angle glaucoma

  2003cites this paper
• Topical Bimatoprost

  2002cites this paper
• Hypertonie oculaire et glaucome à angle ouvert : l'apport des grandes études cliniques dans la pratique quotidienne

  2002cites this paper
• Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

  2002cites this paper
• The European glaucoma prevention study design and baseline description of the participants.

  2002cites this paper
• Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.

  2002cites this paper
• An update on bimatoprost in glaucoma therapy

  2002cites this paper
• [Ocular hypertension and glaucoma: the contribution of large studies to daily practice].

  2002cites this paper
• Travoprost – a new prostaglandin analogue for the treatment of glaucoma

  2002cites this paper